Roles of liver innate immune cells in nonalcoholic fatty liver disease.
about
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individualsNon-alcoholic fatty liver disease: what the clinician needs to know.Glycosyltransferases and non-alcoholic fatty liver diseaseThe Role of Dendritic Cells in Fibrosis Progression in Nonalcoholic Fatty Liver DiseaseReview article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions?Studying non-alcoholic fatty liver disease with zebrafish: a confluence of optics, genetics, and physiologyIL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease ProgressionPathogenesis of Nonalcoholic Steatohepatitis: Interactions between Liver Parenchymal and Nonparenchymal CellsThe Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis.Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation.The imbalance of Th17/Treg cells is involved in the progression of nonalcoholic fatty liver disease in mice.Proteomic and genomic studies of non-alcoholic fatty liver disease--clues in the pathogenesisSteatosis and steatohepatitis: complex disorders.The effect of citrus peel extracts on cytokines levels and T regulatory cells in acute liver injury.GFT505 for the treatment of nonalcoholic steatohepatitis and type 2 diabetes.RORα decreases oxidative stress through the induction of SOD2 and GPx1 expression and thereby protects against nonalcoholic steatohepatitis in mice.Adipocyte dysfunction in a mouse model of polycystic ovary syndrome (PCOS): evidence of adipocyte hypertrophy and tissue-specific inflammation.Effects of indoleamine 2,3-dioxygenase deficiency on high-fat diet-induced hepatic inflammationMechanism of the effect of glycosyltransferase GLT8D2 on fatty liver.Human immunodeficiency virus infection and the liverAnimal Models Correlating Immune Cells for the Development of NAFLD/NASH.C/EBP homologous protein-induced macrophage apoptosis protects mice from steatohepatitisGlycosyltransferase GLT8D2 positively regulates ApoB100 protein expression in hepatocytes.The microbiota maintain homeostasis of liver-resident γδT-17 cells in a lipid antigen/CD1d-dependent manner.The role of the complement system in metabolic organs and metabolic diseases.Immune cells and metabolic dysfunction.Virologic and immunologic aspects of HIV-hepatitis C virus coinfection.Expression of mediators of purinergic signaling in human liver cell lines.IFN-γ deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet.Anti-oxidative and anti-inflammatory effects of spirulina on rat model of non-alcoholic steatohepatitis.HIV Infection and TLR Signalling in the Liver.STAT6 promotes bi-directional modulation of PKM2 in liver and adipose inflammatory cells in rosiglitazone-treated mice.iNKT cells prevent obesity-induced hepatic steatosis in mice in a C-C chemokine receptor 7-dependent manner.Innate immune reactivity of the ileum-liver axis in nonalcoholic steatohepatitis.Altered phenotype and functionality of circulating immune cells characterize adult patients with nonalcoholic steatohepatitis.Phagocytic function of Kupffer cells in mouse nonalcoholic fatty liver disease models: Evaluation with superparamagnetic iron oxide.Immunotherapy with oral administration of humanized anti-CD3 monoclonal antibody: a novel gut-immune system-based therapy for metaflammation and NASH
P2860
Q22299426-400DE15C-FBEC-496F-A970-FE40F22E99FDQ24563068-D1B05AD3-8037-4706-9E19-AC0628C065F3Q26764913-5A2988AC-5B9E-420C-9C85-1F69C3F237A6Q26784452-3C5AB458-AB03-4027-9546-40AA4EE39BA5Q26998093-761D74AF-0F15-42F5-A94D-F8791D806477Q27010291-08B2CAED-0B48-42CE-A860-923D25F08646Q27025620-2F28A9E0-DB70-4229-AF9D-16B88A11C3FFQ28071596-C4C5017F-4486-43DB-87CE-31E529B322C3Q30382395-6890F396-D906-471A-A24D-329E248BD844Q33755829-E9EE9D75-9BB2-461D-8A49-8A3A7B602F54Q33831012-B3E3E989-799F-414F-81DE-0BEDBD841F8FQ33886918-3A601D43-0234-4830-A1C5-2EF9311C6134Q33907632-609D151A-ED5F-4CEF-BB47-EEC2E1B44B43Q34003187-CBC74036-946F-46B2-A60D-25873C251F5EQ34041838-A5200098-D979-4088-94C7-0AA76F1CC67BQ34431785-34545527-A743-4A28-ACBE-56E2E64A4C21Q34465368-EBFE4EFA-8B7E-4B7C-91A1-5A2D785CCBA1Q34988970-6797FA3C-2A43-499C-9F9E-D65829B4B3A9Q35588261-AC6E3289-D98B-45D9-A6D2-08FBFC0A1C1EQ35875848-371C67DC-463A-43CE-A4A3-229CADA68CAFQ36245960-0BE5FBA4-D40D-4571-883E-6DBAE6863225Q36967242-B10AB619-A888-42FB-BA36-A2B85A7A1605Q37375305-4EAE04C5-17C2-446C-AAD4-25CBFF073B88Q37581353-99174147-4055-47FA-990E-E5529E78F0A3Q38107674-B4D0F8A8-2540-42DE-976D-948EC531B18AQ38161295-ADF8FB1C-421B-4947-A9C8-E324A6AE2767Q38900456-1110A2F1-87DC-46A8-BE31-A916FB026560Q38959199-8BEE2DE6-C100-49CF-9A76-82B75B3C1BA1Q39077154-2CCDE1F7-D520-40A9-8E94-494D8BFE2FAEQ41435356-4820D109-4CCA-443D-905E-A9542ACCEF46Q41814282-5F1F0355-BA99-46BC-A65F-EBE6D685F80FQ41863806-A3319B6A-6DEE-4035-A72F-11DD285E7093Q48234451-0E4C0235-825F-46B1-8563-1D51B141419EQ50516235-2EA24CCF-0250-471B-96B6-6B17F10422ADQ50615299-29526B03-8426-4DA3-A2FC-E4A31F2C9AABQ53063351-9E314922-3266-420A-9DA1-3124911D2FE8Q57210121-BC681623-D51B-429A-A342-A68914CF2697
P2860
Roles of liver innate immune cells in nonalcoholic fatty liver disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Roles of liver innate immune cells in nonalcoholic fatty liver disease.
@en
Roles of liver innate immune cells in nonalcoholic fatty liver disease.
@nl
type
label
Roles of liver innate immune cells in nonalcoholic fatty liver disease.
@en
Roles of liver innate immune cells in nonalcoholic fatty liver disease.
@nl
prefLabel
Roles of liver innate immune cells in nonalcoholic fatty liver disease.
@en
Roles of liver innate immune cells in nonalcoholic fatty liver disease.
@nl
P2860
P356
P1476
Roles of liver innate immune cells in nonalcoholic fatty liver disease.
@en
P2093
P2860
P304
P356
10.3748/WJG.V16.I37.4652
P407
P577
2010-10-01T00:00:00Z